We wish to inform about the regulatory approach concerning the use of N-acetylcysteine (NAC) as an ingredient in borderline products.

Based on safety concerns and lack of conclusive evidence supporting the benefits of NAC, it has been determined that: N-acetylcysteine (NAC) should not be permitted for use in borderline products.

This decision reflects a precautionary approach to safeguard public health and ensure regulatory compliance.

‍